Results 111 to 120 of about 21,002 (228)

VII КОНГРЕСС С МЕЖДУНАРОДНЫМ УЧАСТИЕМ «РАЗВИТИЕ ФАРМАКОЭКОНОМИКИ И ФАРМАКОЭПИДЕМИОЛОГИИ В РОССИЙСКОЙ ФЕДЕРАЦИИ» [PDF]

, 2015
VII CONGRESS WITH INTERNATIONAL PARTICIPATION «DEVELOPMENT OF PHARMACOECONOMICS AND PHARMACOEPIDEMIOLOGY IN RUSSIAN FEDERATION»VII КОНГРЕСС С МЕЖДУНАРОДНЫМ УЧАСТИЕМ «РАЗВИТИЕ ФАРМАКОЭКОНОМИКИ И ФАРМАКОЭПИДЕМИОЛОГИИ В РОССИЙСКОЙ ...
Статья Редакционная
core  

National and Individual‐Level Economic Burden of Local Corticosteroid Use and Concomitant Use of Multiple Local Corticosteroid Formulations—A Nationwide Cohort Study

Clinical &Experimental Allergy, Volume 56, Issue 10, Page 1230-1232, October 2026.
Kjell Erik Julius Håkansson, Jonas Bækdal, Inge Raadal Skov, Steven Arild Wuyts Andersen, Zarqa Ali, Anders Løkke, Rikke Ibsen, Ole Hilberg, Howraman Meteran, Claus Rikard Johnsen, Vibeke Backer, Charlotte Suppli Ulrik   +11 more
wiley   +1 more source

Pharmacoeconomic

Bulletin of Faculty of Pharmacy Cairo University, 2014
Community-acquired pneumonia (CAP) is a serious and widespread infection due to its high incidence, morbidity, mortality and increased healthcare costs. This study aimed at investigating antibiotic combination regimen containing fluoroquinolone (Group A) and antibiotic combination regimen not containing fluoroquinolone (Group B) in terms of ...
Weiam A. Harwan, Maggie M. Abbassi, May M. El-Attar, Samar F. Farid   +3 more
openaire   +1 more source

Investigation of the factors affecting health economics and pharmacoeconomics.

, 2022
Διπλωματική εργασία--Πανεπιστήμιο Μακεδονίας, Θεσσαλονίκη, 2022.In the context of this MBA thesis, the fundamental concepts of health economics and pharmacoeconomics are introduced.
Σκαρλατούδης, Χρήστος
core  

Anaesthesia pharmacoeconomics [PDF]

Canadian Journal of Anaesthesia, 1993
openaire   +2 more sources

Analysis of the knowledge and skills of physiotherapists and physiotherapy students regarding pulmonary rehabilitation in post-COVID-19 patients

BMC Medical Education
Background Pulmonary rehabilitation plays a crucial role in the recovery of patients after COVID-19. Because training standards and clinical exposure differ internationally, the present findings should be interpreted within the Polish educational and ...
Dorota Kopciuch, Krzysztof Ciosek, Kinga Adamska, Natalia Chojara, Anna Paczkowska, Tomasz Zaprutko, Piotr Ratajczak, Elżbieta Nowakowska, Krzysztof Kus   +8 more
doaj   +1 more source

ТЕЗИСЫ VII КОНГРЕССА С МЕЖДУНАРОДНЫМ УЧАСТИЕМ «РАЗВИТИЕ ФАРМАКОЭКОНОМИКИ И ФАРМАКОЭПИДЕМИОЛОГИИ В РОССИЙСКОЙ ФЕДЕРАЦИИ» [PDF]

, 2015
VII Congress with International Participation «Development of Pharmacoeconomics and Pharmacoepidemiology in Russian Federation»Тезисы VII конгресса с международным участием «Развитие фармакоэкономики и фармакоэпидемиологии в Российской Федерации», 4-5 ...
Статья Редакционная
core  

Valuation of EQ-5D-5L Health States: A Comparison of Seven Asian Populations

, 2018
10.1080/14737167.2019.1557048Expert Review of Pharmacoeconomics & Outcomes Research194445 ...
mihir Gandhi, juntana Pattanaphesaj, Gordon Liu, Jeonghoon Ahn, Eliza Wong, Nan Luo, Fredrick Dermawan Purba, minwoo Jo, Jan Busschbach, Zhihao Yang, Asrul Shafie, pei wang, Gandhi, M, Liu, GG, Yang, Zhihao, Purba, Fredrick, Wang, P, Wong, ELY, Pattanaphesaj, J, Luo, N, 안정훈, Shafie, AA, Jo, MW, Ahn, J, van Busschbach, Jan; id_orcid   +24 more
core   +1 more source

Pharmacoeconomics in formulary decision making [PDF]

, 2015
Objectives: To assess the knowledge of pharmacoeconomic (PE) information in patient groups, healthcare professionals, Government Formulary List Advisory Committee (GFLAC) and Pharmaceutical Research Based Industry Malta Association (PRIMA) members ...
Magrin Sammut, Sylvana, Zarb Adami, Maurice   +1 more
core  

Identifying optimal ALK inhibitors in first- and second-line treatment of patients with advanced ALK-positive non-small-cell lung cancer: a systematic review and network meta-analysis

BMC Cancer
Objectives To compare the efficacy, safety and effects on quality of life of different ALK-inhibitors for global and Asian patients with advanced ALK-positive non-small-cell lung cancer (NSCLC).
Mingye Zhao, Taihang Shao, Hanqiao Shao, Caicun Zhou, Wenxi Tang   +4 more
doaj   +1 more source